PubHealth.info® (An Information Portal on Public Health Issues / Topics, Presented in Collaboration with PakMed Biomedical Solutions)

[PubHealth.info Homepage] [Category Homepage] [Disclaimer/Copyrights] [Feedback]


Thank you for your kind visit to PubHealth.info®, an information portal created in technical collaboration with PakMed Biomedical Solutions * * * PubHealth.info® presents hundreds of thousands of informative Web pages on a variety of public health issues / issues * * * An ultimate source of information for teachers, students and research workers who need to find information on various public health issues, like population planning, contraception, HIV AIDS, STDs, maternal and child health, communicable and non-communicable disease, etc. * * * PubHealth.info® regularly updates the repository of these hundreds of thousands of informative Web pages * * * PubHealth.info® is one of the world's largest repositories and information portals with online Web pages on public health issues particularly those pertaining to developing countries!

PubHealth.info® (a subsidiary of PakMed) presents scientific information mainly based on abstracts of articles published on a variety of public health issues/topics, particularly encompassing population planning, disease prevention, maternal and child health, and communicable and non-communicable diseases (like HIV AIDS, malaria, etc) that are affecting a significant portion of population in developing and developed countries. Here you can find abstracts of articles published on a variety of public health topics under category "Contraception (Birth Control) and Family Planning". Contraception (birth control) is a regimen of one or more actions, devices, or medications followed in order to deliberately prevent or reduce the likelihood of a woman becoming pregnant or giving birth. Therefore contraception is the utilization of various and sundry surgical procedures, devices, practices, agents, or drugs with the intention of preventing conception or impregnation (pregnancy). Methods and intentions typically termed birth control may be considered a pivotal ingredient to family planning. Birth control is a controversial political and ethical issue in many cultures and religions, and although it is generally less controversial than abortion specifically.

Here you can find more than 42,000 article titles on "Contraception (Birth Control) and Family Planning" , along with their abstracts and bibliographic information (one of the world's largest collections of article titles on this topic), mentioned in various lists that are sorted/arranged according to the years of publication. You can view the bibliographic details and abstracts of these articles, by clicking the title of your required article. To view other lists of articles in the same category "Contraception (Birth Control) and Family Planning", please visit "Category Lists Homepage" or select a list from the following dropdown list of article titles.

 

List 79: Articles 39001-39500 (500 Articles)

To view other lists in the same category, please VISIT LISTS HOME PAGE or select a list from the above dropdown list of article titles
  1. Islamic and Catholic traditional and liberal opinions on birth control.
  2. It doesn't come cheap: family planning and the poor.
  3. IUD). (Use of intrauterine contraceptives (IUDs) [Zur Anwendung intrauteriner Kontrazeptiva.]
  4. Jamaica: a survey of communications, information and education programs in family planning. Survey report.
  5. KAP surveys and evaluation of family planning programs.
  6. Kenya: training social workers for information and education in family planning.
  7. Kenya; developing a family planning communications plan for 1970-1971. (Abstract only)
  8. The knight Nickolls and birth control. [Le chevalier Nickolle et la prevention des naissances.]
  9. Knowledge in "family planning" amongst different sections of population in an educational and industrial campus.
  10. Knowledge of and employment of contraceptives by young mothers. [Unge modres viden om og benyttelse of antikonception.]
  11. Knowledge of contraceptive techniques among a hospital population of low socio-economic status.
  12. Knowledge of what? Elegance and relevance in population and family planning research.
  13. Knowledge, attitude and behavior of middle and high school teachers with regard to population and family planning education.
  14. Korea/Taiwan 1969: report on the national family planning programs.
  15. Kymographic studies of the Fallopian tubes after insertion of intrauterine contraceptive devices using the Lippes loop and the nylon ring.
  16. Laboratory studies and contraceptives. [Die Laboratoriumsuntersuchungen und das Empfangnisverhutungsmittel.]
  17. Lactation and genital involution effects of a new low-dose oral contraceptive on breast-feeding mothers and their infants.
  18. Laparoscopic tubal sterilization: long-term contraception. [Laparoskopische Tubensterilisation--Kontrazeptivum auf Dauer.]
  19. Latest development in contraceptive technology.
  20. An evaluation of the intrauterine contraceptive device.
  21. Evaluation of the rhythm method as a family planning method.I. Effectiveness among low socioeconomic groups in Cali, Colombia. [Evaluacion de la continencia periodica como metodo de planificacion familiar. I. Efectividad entre grupos socioeconomicos bajos en la ciudad de Cali, Colombia.]
  22. Every child a wanted child. Report of a two-day conference on family planning techniques.
  23. An examination of the problem of unwanted population growth in Africa and the existing facilities for training family planning personnel.
  24. Experience in the education of couples in birth control in underdeveloped countries -- islands of Reunion and Mauritius. [Experience d'education des couples pour la regulation des naissances en pays sous-developpes -- iles de la reunion et maurice.]
  25. Experience with a sequential oral contraceptive. [Erfaringer med et sekventielt peroralt antikonceptionspraeparat.]
  26. Experience with chlormadinone acetate in continuous low dose as an oral contraceptive.
  27. Experience with double-coil intrauterine contraceptive device.
  28. Experience with oral contraceptives in a post-partum program.
  29. Experience with the use of sequential estrogens and gestagens for contraception. [Opyt dvukhfaznovo primeneniya estrogenov i gestagenov dlya kontraktseptsii.]
  30. Experience with three minipills preparations with low dose progestagens for oral contraception. [Erfahrungen mit drei minipillen Praparate mit niedrig dosierten Progestagenen zur oralen Kontrazeption.]
  31. Experiences in family planning program evaluation in Taiwan, Republic of China.
  32. Experiences in intrauterine contraception with the DANA SuperIUD. [Erfahrungen in der interuterinen Kontrazeption mit dem IUD DANA Super.]
  33. Experiences with contraception by Dana-Super intrauterine contraceptive devices. [Doswiadczenia nad antykoncepcyjnym dzialaniem wewnatrzmacicznych wkladek typu DANA-Super.]
  34. Experiences with family-planning clinics in Washington, D.C.
  35. Experiences with non-stop daily use of .5 mg chlormadinone acetate as a contraceptive.
  36. Experts agree OC most effective contraceptive.
  37. An exploratory study of troops and their families practicing contraception.
  38. Extending family planning services.
  39. Extrauterine pregnancies during oral contraception. [Grossesses extra-uterines sous contraceptif oral.]
  40. Extrauterine pregnancy with intrauterine contraception. [Extrauterin graviditet ved intrauterin prevensjon.]
  41. Eye side effects of contraceptives. [Troubles oculaires et contraceptifs.]
  42. Factors associated with involvement of low-income women in a public family planning program.
  43. Factors in failure; the physiology of intravaginal contraceptive failure.
  44. Factors in the use and non-use of contraceptives by sexually active black adolescents.
  45. Factors that influence the persistent and non-persistent use of the intra-uterine contraceptive device and the oral pills among low income families.
  46. Failure of a pure progestogen contraceptive of affect serum levels of iron, transferrin, protein-bound iodine, and transaminase.
  47. Failures of contraception on the lower dose ethinyl estradiol sequential therapy: a clinical trial.
  48. Family planning -- ends and means.
  49. Family planning activities in a democratic context: the case of Venezuela.
  50. Family planning and contraception.
  51. Family planning and fertility in Tunisia.
  52. Family planning and maternal and child health.
  53. The importance of the pediatrician in family planning. (Ceylon)
  54. Incidence of candida albicans in women using oral contraceptives.
  55. Incidence of vaginal moniliasis in women using oral contraceptives. [Frecuencia de moniliasis vaginal en mjeres que emplean anticonceptivos por via oral.]
  56. Increased antipyrine half-life in women taking oral contraceptives.
  57. Increased danger of oral contraceptives for diabetics. [Danger accru des anovulants chez la diabetique.]
  58. India's family planning program in the seventies. pt. 1. The problem, the task, the performance, the future.
  59. India's family planning program in the seventies: part 2, the government's response to the population problem--description and analysis, by sector.
  60. India-family planning organization and planning, services.
  61. India: UN mission evaluation of the family planning program.
  62. Indication for a low-dosage contraceptive. [Indicacao contraceptiva de baixa dosagem.]
  63. Induction of hepatic delta-aminolevulinic acid synthetase by oral contraceptive steroids.
  64. Infertility services in a family planning clinic.
  65. The influence of an oral contraceptive on glucose-, F.F.A.-, triglyceride- and insulin levels after glucose loading.
  66. Influence of hormonal contraception on sex life. [Influence de la contraception hormonale sur la vie sexuelle.]
  67. Influence of mono- and biphasic oral contraceptives on colpitis of various etiologies. [Der Einfluss mono- und biphasischer Ovulationshemmer auf Kolpitiden unterschiedlicher Atiologie.]
  68. The influence of oral contraceptive and progestational drugs upon the mechanical activity of the non-pregnant human uterus in vivo.
  69. Influence of oral contraceptives on clinical chemical laboratory values. [Einfluss oraler Ovulationshemmer auf klinisch-chemische Laborwerte.]
  70. The influence of pregnancy and oral contraceptive steroids on the concentration of plasma proteins: studies with a quantitative immunodiffusion method.
  71. The influence of sex, age, synthetic oestrogens, progestogens and oral contraceptives on the excretion of urinary tryptophan metabolites.
  72. The influence of two different doses of HMG in counteracting the inhibitory effect of an oral contraceptive observed at laparotomy.
  73. Information and education program for Tanzania's Family Planning Association.
  74. Inhibition of sperm capacitation in vitro by contraceptive steroids.
  75. Injectable contraceptive with prolonged action. [Un contraceptif injectable a effet prolonge.]
  76. Injectable long-acting progestogens for contraception.
  77. Injectable steroids as a method of contraception.
  78. Integration of family planning into the national health care program of the German Democratic Republic. [Die Integration der Familienplanung in den Gesundheitschutz der Deutschen Demokratischen Republik.]
  79. Integration of family planning with maternal and child health: experience in Taiwan, Republic of China.
  80. Side effects of contraceptive drugs. [Nebenwirkungen der medikamentosen antikonzeption.]
  81. Side effects of hormonal contraception. [Nebenwirkungen der hormonalen Kontrazeption.]
  82. Side effects of oral contraceptives on the eye.
  83. Side effects of the oral contraceptive Ovosiston on the blood coagulation system. [Nebenwirkungen des oralen Kontrazeptivum Ovosiston auf das Blutgerinnung ssystem.]
  84. Simultaneous immunosuppression and contraception. [Immunsuppression und Kontrazeption gleichzeitig.]
  85. The Singapore family planning program: further evaluation date.
  86. Sixth survey - 1961: progress of family planning.
  87. Social development and planned parenthood.
  88. A socio-demographic analysis of family planning in a rural area of East Pakistan.
  89. Socio-economic status and family planning knowledge, attitudes and practices in rural East Pakistan.
  90. Socio-sexual aspects of oral contraception.
  91. Some barriers to the use of more effective methods of contraception.
  92. Some observations on intrauterine contraceptive device (Lippes loop)
  93. Southeast Asia Ministerial Conference on Family Planning and Population, Juala Lumpur, Oct. 1970.
  94. Soviet Union (Family planning)
  95. Special programs related to post-partum family-planning program.
  96. Speech. (Family planning in India.)
  97. Standards of medical education in human reproduction and planned parenthood.
  98. Statement of the International Planned Parenthood Federation on the future of family planning associations.
  99. Statement on the risk of thromboembolism during oral contraception. [Faisons le point sur le risque thrombo-embolique pendant la prise de contraceptifs oraux.]
  100. Statement [on public health aspects of oral contraceptives]
  101. Sterilization and family planning.
  102. Sterilization, on alternative to contraceptive pills. [Sterilisering - ett alternativ till p-piller.]
  103. 1st experiences with Ovosiston in a new dosage - a comparative study of oral contraception with 'old' and 'new' Ovosiston."Experiences with Ovosiston in contraception. II. Reply to the viewpoint of D. Kuhne. ["Erste Erfahrungen mit Ovosiston in neuer dosierung - eine vergleichende Betrachtung der oralen Kontrazeption mit Ovosiston 'alt' und 'neu'." "Erfahrungen mit Ovosiston zur Konzeptionsverhutung. II."]
  104. 46,XY female: anti-androgenic effect of oral contraceptive? 46,XY XY female: anti-androgenic effect of oral contraceptive?
  105. Ability tests in female employees of railway traffic control system on long-term contraceptive therapy.
  106. Abortion: the rearguard in birth control.
  107. Acute intermittent porphyria and hormones. Treatment with oral contraceptives. [Akute intermittierende Porphyrie und Hormone. Zur Frage der Behandlung mit Ovulationshemmern.]
  108. Adrenosem therapy for bleeding coincident with the use of intrauterine contraceptive devices: a double blind study.
  109. Adverse effects of contraceptive steroids on the liver. [Efectos indeseables de los esteroides anticonceptivos sobre el higado.]
  110. Adverse effects of contraceptives. 3. Effects on blood coagulation. The problem of thrombosis. [Efecto sobre la coagulacion de la sangre. El problema de la trombosis.]
  111. Adverse effects of contraceptives. 4. The problem of potential carcinogenic effects of contraceptive steroids. [Elproblema del efecto carcinogenico potencial de los esteroides anticonceptivos.]
  112. Adverse reactions to oral contraceptives. Report of a case of cholestasis.
  113. African society and attitudes to family planning.
  114. Albumin metabolism in female rabbits treated with an oral oestrogen-progestogen contraceptive.
  115. The alpha-fetoprotein test in pregnant women, women on oral contraceptives, newborn babies, and pyridoxine-deprived baboons.
  116. Alternative modes of delivering family planning services.
  117. Analysis of a family planning program in Guatemala.
  118. Analysis of bleeding patterns and resumption of fertility following discontinuation of a long acting injectable contraceptive.
  119. Analysis of oral contraceptive use through multiple decrement life table techniques.
  120. An analysis of the progress in family planning programme in Mysore State.
  121. Appendices. (Family planning in Great Britain)
  122. The application of intrauterine devices with the goal of contraception. [Primenenie vnutrimatochnykh sredstv dlya tselei kontratseptsii.]
  123. Aspects of hormonal birth control. [Perspektiven hormoneller Empfangnisregelung.]
  124. Assessing the demographic effect of a family planning programme.
  125. Assessment of a family planning program: contraceptive services and fertility in Atlanta, Georgia.
  126. Assessment of hormonal constitution variants in relation to the prescription of oral contraceptives. [Die Beurteilung hormonaler Konstitutionsvarianten im Hinblick auf die Verordnung von oralen Kontrazeptiva.]
  127. An assessment of the hazards and metabolic alterations attributed to oral contraceptives.
  128. Assumptions and suggestions concerning the organization of the family planning Programme: in particular, as the programme relates to education and information activities.
  129. Atlanta area family planning services: a data system for service and evaluation.
  130. Attempts to select a suitable hormonal contraceptive during lactation.
  131. Attitude concerning birth control related to age of women] [tables. [Szuletsszabalyozasi magatartas a nok eletkora szering.]
  132. Attitude toward birth control and cognitive consistency: theoretical and practical implications of survey data.
  133. Attitudes of married college students on overpopulation and family planning.
  134. Attitudes toward family planning among peri-urban Africans in Uganda.
  135. Atypical cytology with contraceptive hormone medication.
  136. Bacteriological study on the users of intrauterine contraceptive devices.
  137. Barrier methods of contraception.
  138. Beyond family planning.
  139. Bibliography (On medical history of contraception)
  140. Biochemical changes and implications following long-term use of oral contraception.
  141. Biologic mode of action of the Lippes loop in intrauterine contraception.
  142. Birth control after 1984.
  143. Birth control after 1984: a realistic appraisal of future contraceptive developments.
  144. Birth control and induced abortion. [El control de la natalidad y el aborto provocado.]
  145. Birth control and sex ratio.
  146. Birth control by the FDA. (Letter to the editor)
  147. Birth Control by the intra-uterine device.
  148. Birth control by the pill.
  149. Choosing a birth control method.
  150. Choosing a method. (Contraception.)
  151. Christian education programs concerned with family planning in Peru. [Programmas de orientacion Cristiana en relacion con la regulacion de la natalidad en el Peru.]
  152. Chromosomal studies in children born to mothers who previously used hormonal contraceptives.
  153. Chromosome studies in selected spontaneous abortions: 1. conception after oral contraceptives.
  154. Chronic steroid ingestion and contraception: importance of associated changes in the human uterine corpus mucosa. [Surcharges steroides chroniques et contraception: de l'importance des modifications conjonctives de la muqueuse uterine humaine corporeale.]
  155. Clinical aspects of oral hormonal contraception.
  156. Clinical aspects of Ovulen application as a contraceptive and in gynecological disorders. [Kliniczne aspekty stosowania owulenu w antykoncepcji i w chorobach kobiecych.]
  157. Clinical changes and histological aspect of the endometrium during and after the end of treatment in 5 patients amenorrheic from hormonal contraception. [Evolution clinique et aspect histologique de l'endometre, pendant et apres la fin du traitement, chez 5 patientes rendues amenorrheiques par la contraception hormonale.]
  158. Clinical evaluation of a new combined oral contraceptive.
  159. Clinical evaluation of a vaginal contraceptive foam.
  160. Clinical experience with vaginal contraceptive foam in a new application form.
  161. Clinical studies in the United Arab Republic with SH 850, Eugynon, a low dose oral contraceptive, with special reference to its effects on lactation. [Klinische untersuchungen in der Vereinigten Arabischen Republik mit SH 850, Eugynon, einem niedrig dosierten oralen Kontrazeptivum, unter besonderer berucksichtigung der Laktationsbeeinflussung.]
  162. Clinical study of a once a month oral contraceptive: quinestrol and quingestanol.
  163. Clinical study of a once-a-month oral contraceptive: quinestrol-quingestanol.
  164. Clinical study of a once-a-month oral contraceptive: quinestrol-quingestanol.
  165. Clinical study of a pill-a-month contraceptive: Questrol and Quingestanol.
  166. Clinical study of an oral contraceptive in a single monthly dose; quinestrol-quingestanol. [Estudio clinico de un contraceptivo oral, en dosis unica mensual: quinestrol-quingestanol.]
  167. Clinical tests of a low-dose hormonal contraceptive. [Estudos clinicos con um contraceptivo hormonial de baixa dosagem.]
  168. Clinical trial of intramuscular injection as contraceptive compound.
  169. Colorimetric determination of the progestational steroids in contraceptive tablets.
  170. Colpocytology in users of oral contraceptives. Findings in the praia do pinto ambulatory clinic and in the central hospital of Iaseg, Dept. of Pathological Anatomy. [A colpocitologia nos anovulatorios orais. Estudo feito no ambulatorio da praia do pinto e no hospital central do iaseg, serv. anatomia patolog.]
  171. Colposcopic, cytologic and histologic findings on the portio in contraceptive therapy using Ovosiston. [Kolposkopische, zytologische und histologische Portiobefunde bei Antikon zeptionsbehandlung mit Ovosiston.]
  172. Combined oral contraceptives: a statement by the Committee on Safety of Drugs.
  173. A commentary on oral contraceptive therapy and contact lens wear.
  174. Commentary on the work "Clinical study of an oral contraceptive in the once-a-month dose: quinestrol and quingestanol". [Comentario al trabajo "Estudio clinico de un contraceptivo oral en dosis unica mensual: quinestrol y quingestanol".]
  175. Comments on steroidal contraception. (A report of the meeting of the International Planned Parenthood Federation Central Medical Committee and its advisers, New York, April 11-12, 1970.)
  176. Comments on the current status of contraception. [Pripominky k sourcasnemu stavu nasi antikoncepce.]
  177. Commercial acceptance of oral contraception and the intrauterine device in the United States. Introduction.
  178. Commercial production and distribution of contraceptives.
  179. Communications factors in family planning: channels and media [tables]
  180. Community effects of a hospital-based program experience in Bangkok. In: Zatuchni, G.I., ed. Post-partum family planning: a report on the international program.
  181. Comparative clinical studies with oral contraceptives. [Vergleichende klinische Untersuchungen mit oralen Kontrazeptiva.]
  182. Comparative family planning programme data.
  183. A comparative study of 4 intrauterine contraceptive devices.
  184. A comparative study of blood fibrinolytic activity in normal women, pregnant women, and women on oral contraceptives.
  185. A comparative study on oral contraceptives.
  186. Comparison between changes in tryptophan-nicotinic acid metabolism and blood levels of ceruloplasmin and transferrin during pregnancy and treatment with contraceptives or estrogen. [Confronto tra le variazioni del metabolismo triptofano-acido nicotinico e quelle dei livelli ematici di ceruloplasmina e di transferrina nella gravidanza e nel trattamento con contracettivi o con estrogeni.]
  187. Comparison of the metabolic effects of chlormadinone acetate and conventional contraceptive steroids in man.
  188. The complete family planning service at King's College Hospital.
  189. Complications of the contraceptive pill.
  190. Computer mapping of family planning need and services.
  191. Continuance of contraception post partum by patients of Cook County Hospital.
  192. Continuance of family planning in a health department clinic.
  193. Continuity of contraceptive care provided by the county health departments in Georgia.
  194. Continuous administration of 30 micrograms of D-Norgestrel as a contraceptive to 349 women during 4481 cycles. [Administracion continua de 30 microgramos de D-Norgestrel como anticonceptivo en 349 mujeres durante 4481 ciclos.]
  195. Contraception and sexual life: a therapeutic approach.
  196. Contraception before and during marriage. [Antikoncepcni metody pred manzelstvim a v manzelstvi.]
  197. Contraception by an injectable long-acting estrogen-progestogen agent, Evaluation of cycles, menstrual flows and side effects.
  198. Contraception in general practice. Presentation of data with special attention to the contraceptive pattern. [Svangerskabxforebyggelse i almen laegepraksis. Presentation of materialet specielt med henblik pa antikonceptionsmonstret.]
  199. Contraception or abortion?
  200. Contraception sine Comstockery.
  201. Contraception using the IUD Super DANA with the rhythm method. [Kombinovana antikoncepce IUD Super DANA s cyklickou abstinenci.]
  202. Contraception with a combined low oestrogen dose.
  203. Contraception with a novel sequential preparation (Ovanon) [Antikonzeption mit einem neuartigen Sequenzpraparat--Ovanon.]
  204. Contraception with an intramuscular estrogen-progestogen preparation administered monthly: experience with 4512 cycles of use.
  205. Contraception with chlormadinone acetate in a woman with previous contraceptive jaundice.
  206. Contraception with low dose chlormadinone acetate. Clinical and histological results. [Kontrazeptive Behandlung mit Chlormadinonazetat in niedriger Dosierung. Klinische und histologische Ergebnisse.]
  207. Contraception with medroxyprogesterone acetate: a follow-up study of 1,892 cycles.
  208. Contraception.

     

  209. Contraception.
  210. Contraception: knowledge and practice. The desire for information. [La contraception: oonnaissance et pratique le desir d'information.]
  211. Contraceptive advice for the young. [Die antikonzeptionelle Beratung Jugendlicher.]
  212. Contraceptive effect of varying dosages of progestogen in silastic vaginal rings.
  213. Contraceptive efficiency and side effects of oral microdoses of norgestrel. [Eficacia contraceptiva y efectos secundarios de microdosis orales de norgestrel.]
  214. A contraceptive injection study employing medroxyprogesterone acetate suspension.
  215. Contraceptive licensing rapped.
  216. Contraceptive methods prior to hospital discharge: the first city-wide program.
  217. Contraceptive pill and thyroid nodule.
  218. The contraceptive pill, side effects and personality: report of a controlled double blind trial.
  219. Contraceptive practice among urban blacks in the United States, 1965.
  220. The contraceptive progestagens.
  221. Contraceptive steroids in breast milk: are the hormones in oral contraceptives secreted in breast milk, and, if so, can they affect the baby?
  222. Contraceptive tablets and breast-feeding. [Preventivtabletter och amning.]
  223. Contraceptive technique before the dawn of written history.
  224. Contraceptive technique in antiquity (western world)
  225. Contraceptive technique in eastern cultures.
  226. Contraceptive technology: advances needed in fundamental research.
  227. Contraceptives and dysplasia; higher rate for pill choosers.
  228. Contraceptives and hypertension.
  229. Contraceptives and serum proteins.
  230. Contraceptives and the symphysis. [Kontrazeptivmittel und die Symphyse.]
  231. Contraceptives for students: an invitational symposium.
  232. Contraceptives, brain serotonin, and liver tryptophan pyrrolase. (Letter to the editor)
  233. Contraceptives.
  234. A controlled trial of oral contraceptives in haemophilia.
  235. Cooperation of general practitioner in birth control. Legal questions about prescriptions of the pill. [Die Mitwirkung des praktischen Arztes an der Geburtenregelung. Rechtsfr agen um Verschreibung der "Pille".]
  236. Correlation of folate metabolism and socioeconomic status in pregnancy and in patients taking oral contraceptives.
  237. Cost-benefit analysis of family planning programme in Rajasthan.
  238. Cross-sectional investigation of carbohydrate metabolism in women taking a sequential or combination type oral contraceptive: measurements of blood glucose, plasma insulin and plasma growth hormone during an oral glucose tolerance test.
  239. Cryofibrinogenaemia in patients on oral contraceptives.
  240. Cryofibrinogenaemia in women using oral contraceptives.
  241. Cryofibrinogenaemia in women using oral contraceptives.
  242. Cultural factors in family planning.
  243. Current status of oral contraceptives.
  244. Current status of research in steroid contraception. [Prchled stavu vyzkumu v steroidni antikoncepci.]
  245. Cutaneous eruptions and in vitro lymphocyte hypersensitivity associated with oral contraceptives and mestranol.
  246. Cutaneous side effects of oral contraceptives.
  247. Cyclic and step-up administration of ethynodiol diacetate as an oral contraceptive.
  248. Cytogenetic studies on women using oral contraceptives and their progeny.
  249. The cytohormonal diagnosis under various oral contraceptives. [Die zytohormonale Diagnostik bei verschiedenen oralen Kontrazeptiva.]
  250. Cytologic studies after insertion of intrauterine contraceptive devices.
  251. The cytology of intrauterine contraceptive devices.
  252. Czechoslovakia (Family planning and abortion)
  253. d-Norgestrel combined with ethinyl oestradiol as an oral contraceptive.
  254. Deaths among oral and non-oral contraceptives users.
  255. Deaths among users of oral and nonoral contraceptives.
  256. In defense of the birth control pill.
  257. Delivering family planning services: autonomous vs. integrated clinics.
  258. Demographic comments on the topic of family planning. [Demographische Bemerkunge zum Thema Familienplanung.]
  259. The demographic effects of birth control and legal abortion. [De demografiska effekterna av fodelsekontroll och legal abort.]
  260. Depo-medroxyprogesterone acetate as a contraceptive.
  261. Depression and oral contraception.
  262. Depression and oral contraception. (Letter to the editor)
  263. Depression and oral contraception. (Letter to the editor)
  264. Depressive symptoms and oral contraceptives.
  265. Determinants of involvement of the poor in public family planning.
  266. The development of elevated blood pressure while using oral contraceptives: a preliminary report of a prospective study.
  267. Development of family planning programme in Mysore State.
  268. Developments in steroidal hormonal contraception.
  269. DHEW's new center: the national commitment to family planning.
  270. Dimensions of leadership and involvement of leaders as change agents in health and family planning programme.
  271. Direct mailings to promote family planning.
  272. Discussion of contraceptive technology: current and prospective methods.
  273. Discussion. (Contraception)
  274. Discussion. (Family planning)
  275. Discussion. (Planned parenthood)
  276. Do oral contraceptives cause premalignant endocervical changes?
  277. Double blind study with an oral contraceptive. Preliminary report. [Estudio doble ciego con un anovulatorio oral. Comunicacion preliminar.]
  278. Double-blind trial of a sequential oral contraceptive (Sequens) in the treatment of dysmenorrhoea.
  279. Drug photosensitivity. 1. Light and photo-sensitivities observed during oral contraceptive therapy: a review.
  280. Dural sinus and cerebral venous thrombosis: incidence in young women receiving oral contraceptives.
  281. Economic aspects of family planning.
  282. Education and motivation in family planning program in Iran.
  283. The education-communication partnership in a family planning program.
  284. Edward Foote's Medical Common Sense: an early American comment on birth control.
  285. Effect of a contraceptive -- ovulene -- on mammary carcinogenesis in mice. [Action d'un contraceptif -- ovulene -- sur la carcinogeneses mammaire de souris.]
  286. The effect of age, sex, parity, haemoglobin level, and oral contraceptive preparations on the normal leucocyte count.
  287. Effect of an oral contraceptive agent on blood pressure response to renin. (34640)
  288. Effect of an oral contraceptive on spontaneous running activity of female rats.
  289. The effect of biphasic hormonal contraceptives on hair growth. [Untersuchungen unber den Einfluss antikonzeptiver Zweiphasen-Hormonpraparate auf das Wachstum der Kopfhaare.]
  290. Effect of chlormadin one acetate as a contraceptive agent. [Wirkung von Chlormadinonazetat als Kontrazeptivum.]
  291. Effect of combined oestrogen-progestogen oral contraceptives on serum-levels of alpha 2-macroglobulin, transferrin, albumin, and IgG.
  292. Effect of combined oestrogen-progestogen oral contraceptives, oestrogen, and progestogen on antiplasmin and antithrombin activity.
  293. Effect of contraceptive drugs on the guinea pig teat. [Die Wirkung antikonzeptioneller Medikamente auf die Meerschweinchenzitze.]
  294. Effect of contraceptive pills on the distribution of sexual activity in the menstrual cycle.
  295. Effect of intrauterine contraceptive devices upon human uterine contractility.
  296. Effect of intrauterine contraceptive suture on the response of rat uterus to prolonged estrogen treatment.
  297. The effect of oral contraceptive in the hemorrhagic thrombocytophenic syndrome. [Oralna kontratseptivna sredstva primenena u trombotsitopenijskom khemoragijskom sindromu.]
  298. Effect of oral contraceptive on serum protein concentrations.
  299. The effect of oral contraceptive steroids on bile secretion and bilirubin Tm in rats.
  300. Effect of oral contraceptives on blood lipids.
  301. Effect of oral contraceptives on blood pressure and on plasma renin, renin substrate, and corticosteroids.
  302. Effect of oral contraceptives on leukocyte count in hemophiliacs.
  303. Effect of oral contraceptives on lipoprotein lipase activity and platelet stickiness.
  304. The effect of oral contraceptives on serum folic acid content.
  305. The effect of oral contraceptives on the histology of carcinoma of the breast.
  306. Effect of oral contraceptives on the oral and vaginal mucosa. [Untersuchungen uber den Einfluss oraler Kontrazeptiva auf die Mund-und Vaginalschleimhaut.]
  307. Effect of oral contraceptives on urinary bacterial growth rate.
  308. Effect of some contraceptive steroids on pituitary growth hormone content in female rats (34688)
  309. Effect of some steroid contraceptives on serum lipids of lactating goats.
  310. Effect of supplementary oral estrogen on long-acting injectable progestogen contraception.
  311. Effect of switching with oral contraceptives.
  312. Effect of the new hormonal contraceptive mixtures on the intrauterine environment. [Vliv novych hormonalnich antikoncepcnich smesi na nitrodelozni prostredi.]
  313. Effect of the oral-contraceptive steroids on the ultrastructure of human cervical mucus-a preliminary communication.
  314. The effect of the use of contraceptive pills on live births and natural increase in Alexandria Governorate from 1966 to 1969.
  315. Effect of tranexamic acid (AMCA) in menorrhagia with intrauterine contraceptive devices.
  316. Effect of Washington hearings on contraceptive use.
  317. Effectiveness and complication connected with the Hungarian made IUD (contraceptive cords)
  318. Effectiveness and risks of birth-control methods.
  319. Effects of a surface active contraceptive agent (nonylphenoxypolyethoxyethanol) on the vagina: a new functional approach to assessing the actions on the vagina of spermicides.
  320. Effects of an intra-uterine contraceptive device on mitosis in the rat uterus on different days of pregnancy.
  321. Effects of certain contraceptive pills on uterine myomas.
  322. Effects of combined and low-dose gestagen oral contraceptives on plasma lipids; including individual phospholipids.
  323. Effects of contraception.
  324. Effects of contraceptive progestins on serum gonadotropins. [Action des progestatifs anticonceptionnels sur les gonadotrophines seriq ues.]
  325. The effects of contraceptives on memory span and psychomotor activity.
  326. Effects of different systemic contraceptives on blood fibrinolysis.
  327. Effects of obesity, glucocorticoid, and oral contraceptive therapy on plasma glucose and blood pyruvate levels.
  328. Effects of oral contraceptives (airgram)
  329. Effects of oral contraceptives on carbohydrate metabolism.
  330. Effects of oral contraceptives on carbohydrate metabolism.
  331. The effects of oral contraceptives on carbohydrate metabolism.
  332. Effects of oral contraceptives on clinico-chemical laboratory values. [Einfluss oraler Ovulationshemmer auf klinisch-chemische Laborwerte.]
  333. Effects of oral contraceptives on the fetus. (Letter to the editor)
  334. The effects of programs of birth control education on the practice of induced abortion in Japan.
  335. Effects of some steroid contraceptives on serum inorganic constituents of lactating goats.
  336. Effects of the intrauterine contraceptive device on endometrial enzyme and carbohydrate histochemistry.
  337. Eighth survey - 1965: diffusion of family planning.
  338. El Salvador: a survey of communications, information and education programs in family planning.
  339. Electrical activity of the human uterus in the presence of intrauterine contraceptive device.
  340. Electron microscopic changes in the rat liver after administration of the oral contraceptive lynestrenol. [Elektronenmikroskopische Veranderungen in der Rattenleber nach Verabreichung von dem oralen Antikonzeptionsmittel Lynestrenol.]
  341. Emotional attitudes to contraceptive methods.
  342. Endocrine properties and mechanism of action of oral contraceptives.
  343. Endometrial assessment of the relative potency of contraceptive progestogens.
  344. Endometrial changes in women receiving oral contraceptives.
  345. Endometrial changes in women using hormonal contraceptives for periods up to 10 years.
  346. Endometrial changes in women using hormonal contraceptives for periods up to ten years. (Abstract only)
  347. Endometrial leukocytes in patients using intrauterine contraceptive devices.
  348. Endometrial regeneration in patients discontinuing oral contraceptives.
  349. Endometrium and contraception.

     

  350. Enzymatic characteristics of the monkey endometrium during ovulatory and anovulatory cycles and under hormonal contraception treatment.
  351. Epidemiological and public health aspects of oral contraceptives and thromboembolic disease.
  352. The epidemiology acceptance of post-partum intra-uterine contraception.
  353. The erotic significance of contraceptive methods.
  354. Estimation of contraceptive practice prevalence achieved and births averted by family planning programs.
  355. The estimation of potential fertility for family planning evaluation: a critical discussion.
  356. Evaluating family planning programmes: a few considerations for strengthening evaluation.
  357. Evaluating the training of nurses to do family planning work in India.
  358. Evaluation of a new type of sequential oral contraceptive. [Evaluation d'un contraceptif oral sous une nouvelle forme sequentielle.]
  359. Evaluation of a variation in the simultaneous method of oral contraception. [Valoracion de una variante en el metodo simultaneo de contracepcion oral.]
  360. Evaluation of an injectable progestin-estrogen as a contraceptive. (presented before the Chicago Gynecological Society. March 21, 1969.)
  361. Evaluation of Lippes loop in planned parenthood: present status.
  362. Evaluation of rare adverse effects of systemic contraceptives.
  363. Evaluation of sequential method of contraception with megestrol acetate and ethinyl oestradiol.
  364. Evaluation of the demographic impact of a family planning program.
  365. Family planning and population problems: concepts of 4 different eras.
  366. Family planning and public policy: who is misleading whom?
  367. Family planning as part of basic health services in the Caribbean region.
  368. Family planning attitudes and behavior as a function of the perceived consequences of family planning.
  369. Family planning clinics in the study areas.
  370. Family planning coordinator in a city hospital.
  371. Family planning counseling centers in Switzerland. [Die Beratungsstellen fuer Familienplanung in der Schweiz.]
  372. Family planning counseling services in Switzerland. [Die beratungsstellen fur familien planung in der Schweiz.]
  373. Family planning counselling. (Letter to the editor)
  374. Family planning courses for clinic staff.
  375. Family planning education and school curriculum.
  376. Family planning facilities in the industrial sector in Ahmedabad. A survey.
  377. Family planning facilities in the industrial sector in Baroda. A survey.
  378. Family planning facilities in the industrial sector in Kanpur.
  379. Family planning field laboratory: first years, January-December 1969.
  380. Family planning forms and instructions. [Formularios de planificacion familiar e instrucciones.]
  381. Family planning from the gynecologists point of view. [Familienplanung aus der Sicht des Frauenarztes.]
  382. Family planning hotline.
  383. Family planning improvement through evaluation: a manual of basic principles.
  384. Family planning in a district of Porto Alegre (author's transl) [Planificacao familial num barrio de Porto Alegre.]
  385. Family Planning in Asia.
  386. Family planning in Britain-the doctor's role.
  387. Family planning in China.
  388. Family planning in Colombia.
  389. Family planning in England. [Familienplanung in England.]
  390. Family Planning in five Asian countries.
  391. Family planning in five continents: Africa, America, Asia, Europe, Oceania.
  392. Family planning in Honduras: an analysis of the National Program. [Planificacion familiar en Honduras. Un analisis del Programa Nacional.]
  393. Family planning in Hungary: main results of the 1966 fertility and family planning (TCS) study.
  394. Family planning in industrial units.
  395. Family planning in Iran: a systems approach to program organization and administration.
  396. Family Planning in Kenya.
  397. Family planning in Korea: its operation and its problems.
  398. Family planning in Malaysia today.
  399. (Family Planning in Mysore State)
  400. Family planning in Peru.
  401. Family planning in the developing world.
  402. Family planning in the German Democratic Republic and its significance for the social development of women. [Die Familienung in der Deutschen Demokratischen Republik und ihre Bedeutung fuer die gesellschaftliche Entwicklung der Frau.]
  403. Family planning in the Negro ghettos of Chicago.
  404. Family planning in the next 10 years.
  405. Family planning in the pacific islands: the Fijian example.
  406. Family planning in the United Arab Republic.
  407. Family planning in the USSR.
  408. Family planning in the war on poverty.
  409. Family planning in Vietnam.
  410. Family planning mobile units in Turkish population planning programme.
  411. Family planning organization: the structure and place of evaluation.
  412. Family planning poster enquiry.
  413. Family planning program evaluation by use of a sample survey.
  414. Family planning program of Korea: report of the American Public Health Association Survey Team for AID/Korea.
  415. Family planning programme in Dharwar District.
  416. Family planning programme in India.
  417. Family planning programme in India: an evaluation.
  418. Family Planning Programme in Mysore State, 1956-69.
  419. The Family Planning Programme of Nepal.
  420. Family planning programmes in Africa. (Presented at an Expert Group Meeting held at the Development Centre, Paris, April 6-8, 1970.)
  421. A family planning project in Rhodesia.
  422. Family planning prospects in less developed countries, and a cost-benefit analysis of various alternatives.
  423. Family planning reference book, Taiwan, Republic of China, Volume 3: loop acceptance, 1969.
  424. Family planning service programs: an operational analysis.
  425. Family Planning Services and Population Research Act of 1970.
  426. The Family Planning Services and Population Research Act of 1970.
  427. A family planning services data system.
  428. Family planning services in Atlanta, Georgia.
  429. Family planning services. Hearing before the Subcommittee on Public Health and Welfare of the Committee on Interstate and Foreign Commerce, House of Representatives, ninety-first Congress, second session, on H.R. 15159, H.R. 9107, H.R. 9108, H.R. 9109, and H.R. 15691, bills to amend the Public Health Service Act to provide for special project grants for the provision of family planning services and related research, training, and technical assistance; to establish a commission on population; to provide grants for the construction of population research centers; and to establish a national institute for population research and H.R. 11123 (and identical bills) and S. 2108, bills to promote public health and welfare by expanding, improving and better coordinating the family planning services and population research activities of the federal government, and for other purposes. August 3, 4, and 7, 1970.
  430. Family planning studies the teachers' survey. Part 2: fertility differentials and practice of family planning.
  431. Family planning studies; the teachers survey. 1. Opinions and attitudes concerning the establishment of families.
  432. Family planning training for social service.
  433. Family planning training in medical schools.
  434. Family planning-a health priority.
  435. Family planning.
  436. Family planning.
  437. Family planning. [Familienplanung.]
  438. Family planning. The pace of bumbledom.
  439. Family planning: a silent social revolution.
  440. Family planning: a critical review of the resolution on family planning.
  441. Family planning: respectability at last.
  442. Family Planning: the parents' education and motivation, male fecundity, the contraceptive methods, and child mortality. [Planificacion familiar: la education y motivacion de los padres fecundidad masculina, los metodos contraceptivos, mortalidad infantil.]
  443. Family planning: trends in India.
  444. Family-planning services within hospitals.
  445. Fatal pulmonary embolism during oral contraception. [Fatal lungeemboli ved oral antikonsepsjon.]
  446. A feasibility study of the cost effectiveness of alternative strategies for disseminating the oral contraceptive in NESA countries.
  447. Fees for family planning services.
  448. Femigen forte and mite preparations in contraception and gynecological disorders. [Femigen forte i mite w antykoncepcji i ogolnej praktyce ginekologicznej.]
  449. Fertility and contraception in the rural south of Thailand.
  450. Fertility and family planning in Africa.
  451. Fertility and family planning in Hong Kong--Demographic situation.
  452. Fibroadenomas in patients receiving oral contraceptives: a clinical and pathologic study.
  453. Fibrocystic disease in women receiving oral contraceptive hormones.
  454. Field trial results of long-acting injectable medroxyprogesterone acetate as an injectable contraceptive in 1,730 patients.
  455. Fifth survey - 1959: present situation of birth control.
  456. The fight for acceptance: a history of contraception.
  457. First clinical experience with the use of the oral contraceptive Ovosiston in diabetics. [Erste Klinische Erfahrungen uber die Anwendung des oralen Antikonzipiens Ovosiston bei Diabetikerinnen.]
  458. First experiences with ovosiston in new dosage - a comparative study of oral contraception with 'old and 'new' ovosiston. "Experiences with ovosiston in contraception II." [Erst erfahrungen mit Ovosiston in neuer Dosierung-eine vergleichende Betrachtung der oralen Kontrazeption mit Ovosiston alt und neu. Erfahrungen mit Ovosiston zur Konzeptionsverhutung II.]
  459. Flocculation tests in women taking oral contraceptives. (Letter to the editor)
  460. Folate deficiency and oral contraceptives.
  461. Fourth survey - 1957: has birth control become diffused?
  462. A framework for the selection of family planning program evaluation topics.
  463. Frequency of coitus and variations in libido during oral contraception. [Coitusfrequenz und Libidoveranderungen unter oraler Kontrazeption.]
  464. From gentleman to player (Family planning, England)
  465. From taboo to national policy: the Taiwan Family Planning Program up to 1970.
  466. Further doubts about oral contraceptives.
  467. Further experience with intrauterine contraceptive devices.
  468. The future of contraception.
  469. FY 1969/70 annual report of Nepal Family Planning and Maternal Child Health Project.
  470. Genetic aspects of family planning. [Humangenetische Gesichtspunkte in der Familienplanung.]
  471. Genital Candidiasis and oral contraceptives.
  472. Geographic distribution of need for family planning and subsidized services in the United States.
  473. Ghana national family planning programme: five track training programme.
  474. Glucose tolerance in gestational diabetic women during and after treatment with a combination-type oral contraceptive.
  475. Glucose, insulin, and growth hormone studies in long-term users of oral contraceptives.
  476. The government of India family planning program: a progress report.
  477. Greater emphasis on research held key to birth control gains.
  478. Guidelines for planning the family.
  479. Guidelines governing the use of synthetic progestagens as contraceptives. [Wytyczne stosowania progestagenow syntetycznych w celach antykoncepcji.]
  480. Haematocrit and other haematological values in women using intrauterine contraceptive device.
  481. Has low-dosage therapy with the oral contraceptive Ovosiston any effect on glucose tolerance and liver function? [Hat die Behandlung mit dem oralen Kontrazeptivum Ovosiston in niedriger Dosierung einen Einfluss auf Glukosetoleranz und Leberfunktion?]
  482. Hazards of contraception in relation to effectiveness.
  483. Hazards of oral contraception.
  484. Hazards of oral contraceptive therapy.
  485. Headache and treatment with oral contraceptives.
  486. Health aspects of family planning.
  487. Health aspects of family planning.
  488. Health protection and irreversible contraception -- sterilization -- in women. [Gesundeitsschutz und irreversible Kontrazeption -- Sterilisierung -bei der Frau.]
  489. Health visitors and family planning.
  490. Hemangiomatosis of the liver with thrombosis following use of an oral contraceptive.
  491. Hereditary haemorrhagic telangiectasia and oral contraceptives.
  492. Hereditary haemorrhagic telangiectasia and oral contraceptives.
  493. Hereditary haemorrhagic telangiectasia: aggravation by oral contraceptives.
  494. Hereditary hemorrhagic telangiectasia and oral contraceptives.
  495. Herpes genitalis in women attending Planned Parenthood of New York City.
  496. High-dose estrogen sequential oral contraception. 2. Safety with regard to thromboembolism.
  497. Histological changes in the ovum following failure of intrauterine contraception. [Histologicke zmeny plodoveho vejce pri selhani intrauterinni antikoncepce.]
  498. Histological modification of fibroadenoma of the breast associated with oral hormonal contraceptives.
  499. Historical development of family planning.
  500. HMG Nepal contraceptive policy and program-1970.

To view other lists of the current category of articles, please visit "Category Lists Homepage"


Web PubHealth.info

© Copyrights PubHealth.info®, an information portal on public health. All rights reserved.

This page is optimized to be viewed by Java script enabled Microsoft® Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels.